News + Font Resize -

NPPA fixes/revises prices in respect of 45 formulation packs under DPCO, 2013
Our Bureau, Mumbai | Friday, February 26, 2016, 16:05 Hrs  [IST]

The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed/revised the prices in respect of 45 formulation packs under DPCO, 2013.

In a Notification dated 25.02.2016, the NPPA has fixed/revised the prices of formulations based on bulk drugs Antitetanus Human Immunoglobin, Antitetanus Human Immunoglobin, Paclitaxel Injection (NAB Tortaxel) and Phenobarbitone.

The prices fixed are the revised retail prices in column no. (5) (Exclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the government/NPPA through an order.

The manufacturer/marketing company may add taxes only, if they have paid actually to the government on the price mentioned in column (5).

For different packing material used or, different drug delivery systems or any other special features/forms claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the manufacture/marketing company approaches NPPA for specific price approvals for its formulations.

The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

These revised prices shall be made effective from date of this order as required under paragraph 14(1) of the DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of DPCO, 1995.

These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

The manufacturer or marketing company not complying with the retail prices and conditions specified in notes hereinabove from the date of this order/notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the Essential Commodities Act, 1955, the NPPA said.

Post Your Comment

 

Enquiry Form